文献速递消化与肝胆胰病理

分子发现如何改变肝脏肿瘤病理:简要综述

How Molecular Discoveries Have Changed Liver Tumor Pathology: A Brief Review.
PubMed 文献 · Arch Pathol Lab Med · 2024-01-01

本文以肝纤维板层癌、上皮样血管内皮瘤和肝内胆管癌为例,综述近期分子发现如何催生新的诊断检测、改善预后判断并识别可治疗靶点;同时简述肝细胞腺瘤和肝细胞癌中分子诊断的作用,以及肝内、肝门部和肝外胆管癌的解剖与分子差异。结论认为分子发现推动了诊断与治疗进步,改善了肝脏肿瘤患者的临床管理。

要点

  • 肝纤维板层癌是分子发现转化出新诊断检测的主要范例。
  • 上皮样血管内皮瘤的分子诊断工具有助于改进预后判断。
  • 肝内胆管癌的分子发现识别出可治疗靶点并催生有效疗法。

核心结论

  • 分子发现推动的新诊断检测和治疗靶点改善了肝脏肿瘤患者的临床管理。

研究设计与样本

  • 本文为简要综述,聚焦3个肝脏肿瘤范例并补充肝细胞腺瘤与肝细胞癌的分子诊断信息。

主要发现

  • 肝纤维板层癌被用作分子发现催生新诊断检测的主要范例。
  • 上皮样血管内皮瘤被用作分子诊断工具支持改进预后判断的范例。
  • 肝内胆管癌被用作分子发现识别可治疗靶点并催生有效疗法的范例。
  • 文中描述了肝内、肝门部和肝外胆管癌之间的解剖与分子差异。

临床怎么用

  • 病理实践中可关注分子发现转化的诊断检测在肝纤维板层癌等肿瘤中的应用。
  • 对上皮样血管内皮瘤可借助分子诊断工具辅助预后判断。
  • 对肝内胆管癌可依据分子靶点评估治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Recent molecular discoveries have led to improved understanding of tumor biology and the development of new diagnostic assays. OBJECTIVE: To review primarily 3 examples of liver tumors and to briefly illustrate how recent molecular discoveries have altered clinical liver pathology practice. DATA SOURCES: First, we will discuss fibrolamellar carcinoma, which will be the main focus of discussion, as an example for new diagnostic tests that have been developed as a result of molecular discoveries. Additional information on the role of molecular diagnostics in hepatocellular adenoma and hepatocellular carcinoma will be provided. Second, we will use the example of epithelioid hemangioendothelioma as an example of how new diagnostic tools, based on molecular discoveries, may support improved prognostication. Finally, we will use the example of intrahepatic cholangiocarcinoma as an example of a liver tumor where new molecular discoveries have identified tractable therapeutic targets and led to new effective therapies. This portion of the manuscript will also include a description of the anatomic and molecular differences between intrahepatic, hilar, and extrahepatic cholangiocarcinoma. CONCLUSIONS: Fueled by molecular discoveries, new and better diagnostic tests and therapeutic targets have improved clinical care in patients affected by liver tumors.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Taheri N, Graham RP. How Molecular Discoveries Have Changed Liver Tumor Pathology: A Brief Review. Arch Pathol Lab Med. 2024. PMID: 37639429. doi:10.5858/arpa.2023-0099-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。